Kusko Rebecca L, Brothers John F, Tedrow John, Pandit Kusum, Huleihel Luai, Perdomo Catalina, Liu Gang, Juan-Guardela Brenda, Kass Daniel, Zhang Sherry, Lenburg Marc, Martinez Fernando, Quackenbush John, Sciurba Frank, Limper Andrew, Geraci Mark, Yang Ivana, Schwartz David A, Beane Jennifer, Spira Avrum, Kaminski Naftali
1 Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts.
2 Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Am J Respir Crit Care Med. 2016 Oct 15;194(8):948-960. doi: 10.1164/rccm.201510-2026OC.
Despite shared environmental exposures, idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease are usually studied in isolation, and the presence of shared molecular mechanisms is unknown.
We applied an integrative genomic approach to identify convergent transcriptomic pathways in emphysema and IPF.
We defined the transcriptional repertoire of chronic obstructive pulmonary disease, IPF, or normal histology lungs using RNA-seq (n = 87).
Genes increased in both emphysema and IPF relative to control were enriched for the p53/hypoxia pathway, a finding confirmed in an independent cohort using both gene expression arrays and the nCounter Analysis System (n = 193). Immunohistochemistry confirmed overexpression of HIF1A, MDM2, and NFKBIB members of this pathway in tissues from patients with emphysema or IPF. Using reads aligned across splice junctions, we determined that alternative splicing of p53/hypoxia pathway-associated molecules NUMB and PDGFA occurred more frequently in IPF or emphysema compared with control and validated these findings by quantitative polymerase chain reaction and the nCounter Analysis System on an independent sample set (n = 193). Finally, by integrating parallel microRNA and mRNA-Seq data on the same samples, we identified MIR96 as a key novel regulatory hub in the p53/hypoxia gene-expression network and confirmed that modulation of MIR96 in vitro recapitulates the disease-associated gene-expression network.
Our results suggest convergent transcriptional regulatory hubs in diseases as varied phenotypically as chronic obstructive pulmonary disease and IPF and suggest that these hubs may represent shared key responses of the lung to environmental stresses.
尽管存在共同的环境暴露因素,但特发性肺纤维化(IPF)和慢性阻塞性肺疾病通常是分开研究的,其共同分子机制尚不清楚。
我们应用综合基因组学方法来识别肺气肿和IPF中趋同的转录组途径。
我们使用RNA测序(n = 87)确定慢性阻塞性肺疾病、IPF或正常组织学肺的转录组特征。
与对照组相比,肺气肿和IPF中均增加的基因在p53/缺氧途径中富集,这一发现在使用基因表达阵列和nCounter分析系统的独立队列中得到证实(n = 193)。免疫组织化学证实该途径的HIF1A、MDM2和NFKBIB成员在肺气肿或IPF患者的组织中过表达。通过比对跨越剪接位点的 reads,我们确定与p53/缺氧途径相关的分子NUMB和PDGFA的可变剪接在IPF或肺气肿中比在对照组中更频繁发生,并通过定量聚合酶链反应和nCounter分析系统在独立样本集上验证了这些发现(n = 193)。最后,通过整合相同样本上的平行microRNA和mRNA测序数据,我们将MIR96鉴定为p53/缺氧基因表达网络中的一个关键新调控枢纽,并证实体外调节MIR96可重现疾病相关的基因表达网络。
我们的结果表明,在表型各异的疾病如慢性阻塞性肺疾病和IPF中存在趋同的转录调控枢纽,提示这些枢纽可能代表肺对环境应激的共同关键反应。